June 9, 2024
Alex Pastuszak, MD, PhD named Paterna CEO successor to lead transformation of male fertility care; former CEO and Co-Chairman Edward Rowland retiring.
“For decades, couples facing male infertility lacked options. We’re pioneering new fertility treatments, focused on the male, and offering families solutions and real hope.”
Alexander Pastuszak, MD, PhD, CEO, Paterna
SALT LAKE CITY, UT, UNITED STATES
Paterna BioSciences, a pioneering biotechnology company dedicated to solving male infertility, today announced the appointment of co-founder Alexander Pastuszak, MD, PhD as Chief Executive Officer (CEO). Dr. Pastuszak’s leadership will accelerate Paterna’s seed funding round and advance the company’s in vitro spermatogenesis (IVS) technology through clinical development and commercialization.
Male Infertility: Addressing a Critical Treatment Gap
Male infertility is a significant yet often overlooked factor in reproductive challenges. Of the approximately three million in vitro fertilization (IVF) procedures performed globally each year, roughly 50% fail, with male infertility being responsible for half of those failures. Despite this, the field of male infertility treatment has seen minimal innovation in over three decades. Paterna’s novel IVS technology tackles the long-standing lack of solutions in male fertility care, empowering couples on their path to parenthood. IVS stands to improve male infertility treatment, creating new treatment options for individuals and couples struggling to conceive.
Accelerating Innovation: New Leadership to Drive Commercialization
“It is a privilege to lead Paterna as we advance our mission to solve the substantial challenges of male and couple infertility,” said Alex Pastuszak, MD, PhD, CEO and Co-founder of Paterna BioSciences. “We’re pioneering new science to offer couples real hope and new fertility treatment choices. Our focus is clear – our talented team will advance scientific breakthroughs into clinical success, transforming fertility treatment globally.”
Dr. Pastuszak succeeds Edward Rowland, Paterna’s founding CEO who successfully guided the company through its early development. “Ed created a strong foundation for our future,” said Paterna co-founder and Chief Medical Officer Jim Hotaling. “Alex’s extensive background in male reproductive medicine and healthcare entrepreneurship makes him the ideal leader to take Paterna into its next phase of growth and clinical development.”